Biotech News

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Si-Bone (SIBN)Si-Bone2026-06-25 13:46 ESTConference / presentation

SANTA CLARA, Calif. , Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 23 rd Annual Global Healthcare Conference in New York, NY

Open original release

Related news

Si-Bone

Si-Bone is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States